Lifecome Biochemistry (002868) Stock Price, News, Quotes-Moomoo

CN Stock MarketDetailed Quotes

002868 Lifecome Biochemistry

Watchlist

16.28
+0.63+4.03%

Market Closed Jan 17 15:00 CST

2.53BMarket Cap-8.65P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

The Recent Pullback Must Have Dismayed Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Insiders Who Own 37% of the Company
Simply Wall StDec 22, 2024 22:27 ET
Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Shares Fly 25% But Investors Aren't Buying For Growth
Simply Wall StNov 17, 2024 21:26 ET
Improved Revenues Required Before Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Shares Find Their Feet
Simply Wall StOct 3, 2024 22:22 ET
Lifecome Biochemistry Names Chairman
MT NewswiresMay 22, 2024 05:42 ET
Benign Growth For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) Underpins Stock's 28% Plummet
Simply Wall StApr 25, 2024 20:14 ET
Revenues Not Telling The Story For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) After Shares Rise 30%
Simply Wall StMar 6, 2024 17:03 ET

Comments

Moomoo AI

Mar 6, 2024 16:38

Despite Lifecome BiochemistryLtd's revenue growth, its P/S ratio isn't rising, possibly due to market expectations of future revenue performance tapering off. Investors may face disappointment if the company's revenue growth doesn't keep up with the industry.

Revenues Not Telling The Story For Lifecome Biochemistry Co.,Ltd. (SZSE:002868) After Shares Rise 30%

Moomoo AI

Jan 15, 2024 16:29

Despite strong revenue, Lifecome Biochemistry's growth rates lag behind the industry's predicted 842% growth. Investors may face disappointment if P/S falls in line with recent growth rates. The company's poor three-year revenue trends aren't resulting in a lower P/S as expected. Without significant medium-term performance improvement, preventing P/S ratio decline will be challenging.

Lifecome Biochemistry Co.,Ltd.'s (SZSE:002868) Shares Climb 31% But Its Business Is Yet to Catch Up

Moomoo AI

Jan 12, 2024 17:16

The company's EBIT loss of CN¥127m and the liabilities do not inspire confidence in the company's use of debt. The balance sheet appears strained, and the stock is considered very risky.

Does Lifecome BiochemistryLtd (SZSE:002868) Have A Healthy Balance Sheet?

Heat List

Overall

No Data

Investment Theme

The Pet Economy

Intraday+2.41%